Clinical characteristics of patients undergoing surgical resection of benign liver tumors in Taiwan, an endemic area for hepatocellular carcinoma

Journal of the Formosan Medical Association

Volumn 103, Issue 11, 2004, Pages 824-829

  Hsu, Chih Wei ^a   Lui, Wing Yiu ^a   Chau, Gar Yang ^a   King, Kuang Liang ^a   Loong, Che Chuan ^a   Hsia, Cheng Yuan ^a   Lee, Rheun Chuan ^a   Li, Anna Fen Yau ^a   Wu, Chew Wun ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Liver diseases, surgery; Liver neoplasms; Risk assessment

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ASPIRATION CYTOLOGY; CAVERNOUS HEMANGIOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; ECHOGRAPHY; ENDEMIC DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER ANGIOGRAPHY; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER LOBECTOMY; LIVER NODULE; LIVER RESECTION; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NODULAR HYPERPLASIA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RADIOLOGIST; REVIEW; SAFETY; TAIWAN; TREATMENT INDICATION; UNNECESSARY PROCEDURE;

CARCINOMA, HEPATOCELLULAR; ENDEMIC DISEASES; FEMALE; FOCAL NODULAR HYPERPLASIA; HEMANGIOMA, CAVERNOUS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; TAIWAN;

EID: 12344338292     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Belghiti J, Pateron D, Panis Y, et al: Resection of presumed benign liver tumours. Br J Sury 1993;80:380-3.
2. Trastek VF, van Heerden JA, Sheedy PF, et al: Cavernous haemangiomas of liver: resect or observe? Am J Surg 1983; 145:49-53.
3. Yamagata M, Kanematsu T, Matsumata T, et al: Management of haemangioma of the liver: comparison of results between surgery and observation. Br J Surg 1991;78:1223-5.
4. Brady MS, Coit DG: Focal nodular hyperplasia of the liver. Surg Gynecol Obstet 1990;171:377-81.
5. Department of Health, Executive Yuan. Republic of China: Annual Report of Cancer Registration, 1998.
6. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 1995;22:983-93.
7. Bruix J, Sherman M, Llovet J, et al: Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 2001;35:421-30.
8. Charny CK, Jarnagin WR, Schwartz LH, et al: Management of 155 patients with benign liver tumours. Br J Surg 2001;88: 808-13.
9. Weimann A, Ringe B, Klempnauer J, et al: Benign liver tumours: differential diagnosis and indications for surgery. World J Surg 1997;21:983-91.
10. Terkivatan T, de Wilt JH, de Man RA, et al: Indications and long-term outcome of treatment for benign heptic tumours- a critical appraisal. Arch Surg 2001;136:1033-8.
11. Tanaka Y, Sasati Y, Katayama K, et al: Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography. Hepatology 2000;31:890-8.
12. Lim JH, Kim CK, Lee WJ, et al: Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: accuracy of helical CT in transplant patients. AJR Am J Roentgenol 2000; 175:693-8.
13. Kanematsu M, Hoshi H, Yamada T, et al: Small hepatic nodules in cirrhosis: ultrasonographic CT, and MR imaging finding. Abdom Imaging 1999;24:47-55.
14. Chalasani N, Horlander JC Sr, Said A, et al: Screening of hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol 1999;94:2988-93.
15. Gambarin-Gelwan M, Wolf DC, Shapiro R, et al: Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000;95:1535-8.
16. Levy I, Greig PD, Gallinger S, et al: Resection of hepatocellular carcinoma without preoperative tumour biopsy. Ann Surg 2001; 234:206-9.
17. Lim JH, Choi D, Cho SK, et al: Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 2001; 220:669-76.
18. Huang GT, Sheu JC, Yang PM, et al. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. J Hepatol 1996;25:334-8.
19. Longchampt E, Patriarche C, Fabre M, et al. Accuracy of cytology vs. microbiopsy for the diagnosis of well-differentiated hepatocellular carcinoma and macroregenerative nodule. Definition of standardized criteria from a study of 100 cases. Acta Cytol 2000;44:515-23.
20. Ng KK, Poon RT, Lo CM, et al: Impact of preoperative fine-needle aspiration cytologic examination on clinical outcome in patients with hepatocellolar carcinoma in a tertiary referral center. Arch Surg 2004;139:193-200.
21. Bru C, Maroto A, Bruix J, et al: Diagnostic accuracy of fine-needle aspiration biopsy in patient with hepatocellular carcinoma. Dig Dis Sci 1989;34:1765-9.
22. Jain D: Diagnosis of fine needle aspiration cytology or needle core biopsy. J Clin Gastroenterol 2002;35:S101-8.
23. Ding W, He XJ: Fine needle aspiration cytology in the diagnosis of liver lesion. Hepatobiliary Pancreat Dis Int 2004;3: 90-2.
24. Takamori R, Wong LL, Dang C, et al: Needle tract implantation of hepatocellular carcinoma: is needle biopsy of the liver always necessary? Liver Transpl 2000;6:67-72.
25. Kim SH, Lim HK, Lee WJ, et al: Needle-tract implantation in hepatocellular carcinoma: frequency and CT findings after biopsy with a 19.5-gauge automated biopsy gun. Abdom Imaging 2000;25:246-50.
26. McGill DB, Rakela J, Zinsmeister AR, et al: A 21-year experience with major haemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400.
27. Smith EH: Complications of percutaneous abdominal fine-needle biopsy: review. Radiology 1991;178:253-8.
28. Iwatsuki S, Todo S, Starzl TE: Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet 1990;171:240-6.
29. Nagorney DM: Benign liver tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995;19:13-8.
30. Takayama T, Makuuchi M, Hirohashi S, et al: Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 1990;336:1150-3.
31. Borzio M, Fargion S, Borzio F, et al: Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development. Hepatology 2003;37:72-8.
32. Borzio M, Borzio F, Croce A, et al: Ultrasonography-detected macroregenerative nodules in cirrhosis: a prospective study. Gastroenterology 1997;112:1617-23.
33. Kondo F, Ebara M, Sugiura N, et al: Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 1990;12:59-8.
34. Nakanuma Y, Terada T, Ueda K, et al: Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993;13:1-9.
35. Terada T, Terasaki S, Nakanuma Y: A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy. Cancer 1993;72:1551-15.
36. Arakawa M, Kage M, Sugihara S, et al: Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases. Gastroenterology 1986;91: 198-208.
37. Terasaki S, Kaneko S, Kobayashi K, et al: Histological features predicting malignant transformation of nonmalignant hepatocellular nodules: a prospective study. Gastroenterology 1998;115:1216-22.